Pacira | PCRX - Loan Capital


Pacira reported $363.12M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Astellas Pharma JPY 320B 0 Jun/2026
Bristol-Myers Squibb USD 42.09B 59M Jun/2026
Cara Therapeutics USD 0 0 Mar/2025
Coherus Biosciences USD 51.08M 496K Dec/2025
Heron Therapeutics USD 140.64M 975K Dec/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 37.34B 183M Jun/2026
Ligand Pharmaceuticals USD 446.9M 704K Mar/2026
Nektar Therapeutics USD 60.27M 2.89M Mar/2026
Novo Nordisk DKK 121.79B 2.62B Jun/2026
Omeros USD 403.72M 27.2M Jun/2024
Pacira USD 363.12M 4.53M Jun/2026
Perrigo USD 3.28B 337.7M Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 12.09B 1.92B Jun/2026
Xeris Pharmaceuticals USD 188.81M 32.42M Jun/2026
Zoetis USD 9.05B 3M Jun/2026